New COVID-19 Clinical Trial
Post
Breaking news: A new clinical trial conducted by the Canadian Cancer Society-funded Canadian Cancer Trials Group is the FIRST IN THE WORLD to test an immune-boosting treatment that could prevent severe COVID-19 infections in people with cancer and help them live longer, healthier lives.
This clinical trial holds life-changing potential. If successful, it could reduce symptoms and prevent severe cases of COVID-19 and other serious respiratory infections in people with cancer. And with results anticipated in a matter of months, this could be a glimmer of hope that people affected by cancer need right now.
Learn More about this game-changing clinical trial!
Comments